Early Stage Drug Delivery Companies: Start-ups And Emerging Companies

In the modern regulatory environment, start-ups and smaller companies tend to be less well-known. The costs are increasingly high and its hard to get venture capital funding without  knowing how long it can take to clear government hurdles so if things look promising, companies are acquired instead.  But some are sticking it out and they are trying to gain momentum as they advance their technologies and produce significant clinical data on the road to eventual commercialization of their technologies.  read more

Read the whole article on

More from